期刊文献+

新生儿卡介苗接种相关影响因素分析 被引量:4

Analysis on impact factors of neonate BCG vaccination
暂未订购
导出
摘要 目的:了解重庆市高新区卡介苗(BCG )接种现况,并探讨影响BCG转阳性的相关因素。方法以重庆市九龙坡区石桥铺社区卫生服务中心进行BCG接种的3个月龄以下的婴儿为研究对象,通过 PPD试验,检测BCG接种转阳性情况。结果性别、出生体质量和接种年龄之间转阳性率差异无统计学意义(P>0.05),转阳性率由高到低依次为出生体质量儿、巨大儿、低出生体质量儿;1~2个月龄、2~3个月龄、0~1个月龄;有卡痕转阳性率高于无卡痕,差异有统计学意义(χ2=80.057,P<0.01)。结论性别、出生体质量和接种年龄与BCG接种转阳性率无明显相关,而卡痕有无可从间接上反应新生儿BCG的转阳性情况。 Objective To know the vaccination status of BCG in Gaoxin district of Chongqing and explore the associated impact factors on seroconversion rate .Methods PPD was used to test the seroconversion status after PDG vaccination in infants under 3 months .Results There was no significant differences of seroconversion rate between different sex ,birth weight and vaccination age (P〉0 .05) .But the rate was significantly higher in infants with normal birth weight than that in fetal macrosomia which was signif-icantly higher than that in low-birth weight .The rate was significantly decreased in infants of 1-2 months ,2-3 months and 0-1 months in order .The rate of infant with vaccination scar was significantly higher than that without scar (χ2 =80 .057 ,P〈0 .01) . Conclusion There was no significant differences of seroconversion rate between different sex ,birth weight and vaccination age ,and the scar can indirectly show the seroconversion condition of vaccination .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第4期432-433,436,共3页 Chongqing medicine
基金 国家重大科技专项项目(2009ZX10004-803)
关键词 卡介苗 出生体重 卡痕 BCG vaccine birth weight BCG scar
  • 相关文献

参考文献13

  • 1World Health Organization.Global Tuberculosis Report2012.WHO,Geneva,Switzerland[R].WHO/HTM/TB,2012.
  • 2周勇,吴江南,郑金风.卡介苗预防结核病的效果与策略[J].中华疾病控制杂志,2011,15(8):716-719. 被引量:17
  • 3吴瑞萍,胡亚美,江载芳.实用儿科学[M].6版.北京:人民卫生出版社,1996,427.
  • 4杨锡强,易著文主编.儿科学[M].6版.北京:人民卫生出版社,2006:118-133.
  • 5Arias GM.Advances in the diagnosis of tuberculosis in-fection[J].Arch Bronconeumol,2011,47(10):521-530.
  • 6中华人民共和国卫生部.预防接种工作规范[M].北京:中国法制出版社,2005:193-210.
  • 7Liu JJ,Yao HY,Liu EY.Analysis of factors affecting theepidemiology of tuberculosis in China[J].Int J TubercLung Dis,2005,9(4):450-454.
  • 8张郁玲,袁勤,许丽慧,于小岑,常桂珍.3841例新生儿卡介苗接种效果分析[J].实用预防医学,2008,15(1):239-240. 被引量:5
  • 9Moyo S,Verver S,Hawkridge A,et al.Tuberculosis casefinding for vaccine trials in young children in high-inci-dence settings:a randomised trial[J].Int J Tuberc LungDis,2012,16(2):185-191.
  • 10Kaur S,Faridi MM,Agarwal KN.BCG vaccination reac-tion in low birth weight infants[J].Indian J Med Res,2002,116:64-69.

二级参考文献23

  • 1张俊光.5226名苗族中小学生结核菌素试验结果分析[J].实用预防医学,2006,13(6):1511-1512. 被引量:8
  • 2郭建丽,徐勤,刘玉清.北京市海淀区33所大学新生的结核感染状况调查[J].中华预防医学杂志,2006,40(5):355-358. 被引量:36
  • 3吴逢波,徐珽,陈泽莲,唐尧.136例卡介苗接种致不良反应文献分析[J].中国药房,2007,18(23):1817-1818. 被引量:10
  • 4Styblo K, Meijer J. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem [ J ]. Tubercle, 1976,57 (1) :17-43.
  • 5Fine PEM, Carneiro IAM, Milstein JIB, et al. Issues relating to the use of BCG in intmunization programmes [J].Geneva, 1999.
  • 6WHO. Releve epidemiologique hebdomadaire [J]. WER, 2004, 79(4) :25-40.
  • 7Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis meta-analysis of the pub lished literature [ J ]. JAMA, 1994,271 (9) : 698-702.
  • 8Fine PE. Variation in protection by BCG: implications of and for heterologous immunity IJ]. I.ancet, 1995, 346 (8986): 1339 1345.
  • 9Comstock GW, Palmer CE. Long-term resuhs of BCG vaccination in the southern United States [J ]. Am Rev Respir Dis, 1966,93(2):171 183.
  • 10Tuberculosis Prevention Trial. Trial of BCG vaccines in South In dia for tuberculosis prevention [J ]. Indian J Med Res, 1979,70 : 349-363.

共引文献170

同被引文献46

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部